EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY 4.0

Safety and Efficacy of Metformin for Idiopathic Intracranial Hypertension: A U.S.-Based Real-World Data Retrospective Multicenter Cohort Study

Ahmed Y Azzam, Mahmoud Nassar, Ahmed Saad Al Zomia, Adam Elswedy, Mahmoud M Morsy, Adham A Mohamed, Osman Elamin, Omar S Elsayed, Mohammed A Azab, Muhammed Amir Essibayi, Jin Wu, Adam A Dmytirw und 1 weitere

ASIDE Internal Medicine · 2024

DOI: 10.71079/2024001001 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift ASIDE Internal Medicine, 2024. Verfasst von Ahmed Y Azzam und 12 weiteren Autor:innen. Beteiligte Einrichtung: Montefiore-Einstein Cerebrovascular Research Lab, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY, USA. Die Arbeit nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NINDS NIH HHS, NCATS NIH HHS, National Center for Advancing Translational Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Managing idiopathic intracranial hypertension (IIH) is challenging due to limited treatment options. This study evaluates metformin as a potential therapy for IIH, examining its impact on disease outcomes and safety.

Methods

We performed a retrospective cohort study using the TriNetX database, covering data from 2009 to August 2024. The study included IIH patients, excluding those with other causes of raised intracranial pressure or pre-existing diabetes. Propensity score matching adjusted for age, sex, race, ethnicity, Hemoglobin A1C, and baseline BMI at metformin initiation. We assessed outcomes up to 24 months.

Results

Initially, 1,268 patients received metformin and 49,262 served as controls, showing disparities in various parameters. After matching, both groups consisted of 1,267 patients each. Metformin users had significantly lower risks of papilledema, headache, and refractory IIH at all follow-ups (p

Schlagwörter

Stichwörter der Autor:innen

Idiopathic Intracranial HypertensionMetabolic SyndromeMetforminPseudotumor Cerebri

Autor:innen und Institutionen

  • Montefiore-Einstein Cerebrovascular Research Lab, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY, USA.
  • Department of Medicine, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, New York, USA.
  • College of Medicine, King Khalid University, Abha, Saudi Arabia.
  • Faculty of Medicine, October 6 University, Giza, Egypt.
  • Cairo University Hospitals, Cairo University, Cairo, Egypt.
  • Department of Neurosurgery, Jordan Hospital, Amman, Jordan.

Förderung

  • NINDS NIH HHS
  • NCATS NIH HHS
  • National Center for Advancing Translational Sciences

Zitieren

APA

Azzam, A. Y., Nassar, M., Zomia, A. S. A., Elswedy, A., Morsy, M. M., Mohamed, A. A., Elamin, O., Elsayed, O. S., Azab, M. A., Essibayi, M. A., Wu, J., Dmytirw, A. A., & Altschul, D. J. (2024). Safety and Efficacy of Metformin for Idiopathic Intracranial Hypertension: A U.S.-Based Real-World Data Retrospective Multicenter Cohort Study. ASIDE Internal Medicine. https://doi.org/10.71079/2024001001

Vancouver

Azzam AY, Nassar M, Zomia ASA, Elswedy A, Morsy MM, Mohamed AA, et al. Safety and Efficacy of Metformin for Idiopathic Intracranial Hypertension: A U.S.-Based Real-World Data Retrospective Multicenter Cohort Study. ASIDE Internal Medicine. 2024. doi:10.71079/2024001001

BibTeX
@article{Azzam2024,
  author = {Azzam, Ahmed Y and Nassar, Mahmoud and Zomia, Ahmed Saad Al and Elswedy, Adam and Morsy, Mahmoud M and Mohamed, Adham A and Elamin, Osman and Elsayed, Omar S and Azab, Mohammed A and Essibayi, Muhammed Amir and Wu, Jin and Dmytirw, Adam A and Altschul, David J},
  title = {Safety and Efficacy of Metformin for Idiopathic Intracranial Hypertension: A U.S.-Based Real-World Data Retrospective Multicenter Cohort Study},
  journal = {ASIDE Internal Medicine},
  year = {2024},
  doi = {10.71079/2024001001}
}
Kostenlos starten →